Astellas Pharma (OTCPK:ALPMY) and YASKAWA Electric signed a definitive agreement to establish a joint venture for the development of a cell therapy product manufacturing platform utilizing the ...
Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform using Yaskawa’s dual-arm humanoid robot called Maholo.
YASKAWA's subsidiary, Robotic Biology Institute, has developed Maholo. In addition, the JV will offer platform access to startups and academic institutions, fostering collaboration and innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback